Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Vaccination Dosing in HIV-infected Adults with Low CD4
NCT02732054Phase 4Completed
- Sponsor
- Chiang Mai University
- Start
- Mar 2015
- Primary completion
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Heberbiovac HB in hepatitis B (HBV), sponsored by Chiang Mai University. Started Mar 2015; status: completed.
02
Drugs
Heberbiovac HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02732054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02732054.